Seroepidemiology of low and high oncogenic risk types of human papillomavirus in a predominantly male cohort of STD clinic patients

International Journal of STD and AIDS

Volumn 12, Issue 8, 2001, Pages 516-523

  Slavinsky, J ^a   Kissinger, P ^b   Burger, L ^a   Boley, A ^a   DiCarlo, R P ^a   Hagensee, M E ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY   (United States)

Author keywords

CIN; Epidemiology; HPV; Pap smear; Serology

Indexed keywords

ADULT; ANTIBODY DETECTION; ARTICLE; CANCER RISK; COHORT ANALYSIS; CONDOM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SEROEPIDEMIOLOGY; SEROPREVALENCE; SEXUALLY TRANSMITTED DISEASE; VIRUS CARCINOGENESIS; WART VIRUS;

ADULT; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LOUISIANA; MALE; NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; QUESTIONNAIRES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; TUMOR VIRUS INFECTIONS; URBAN HEALTH;

EID: 0034934754     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462011923615     Document Type: Article

References (44)

1. The epidemiology of genital papillomavirus infections
2. Human papillomaviruses
3. Human pathogenic papillomavirus types: An update
4. Current epidemiology of genital HPV infection: Implications for prevention
5. Oncogenic association of specific human papillomavirus types with cervical neoplasia
6. Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma
7. Risk factors for incident and recurrent condylomata acuminata among women. A population-based system
8. Risk factors for incident and recurrent condylomata acuminata among men. A population-based study
9. Anal cytological abnormalities and anal HPV infection in men with Centers for Disease Control group IV HIV disease
10. HPV infection and disease in men
11. Male sexual behavior and human papillomavirus DNA: Key risk factors for cervical cancer in Spain
12. Human papilloma virus infection among women attending an STD clinic correlated to reason for attending, presence of clinical signs, concomitant infections and abnormal cytology
13. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women
14. Risk factors for HPV infection in women from sexually transmitted disease clinics: Comparison between two areas with different cervical cancer incidence
15. Transmission of cervical human papillomavirus infection by sexual activity: Differences between low and high oncogenic risk types
16. Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior
17. Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and negative women
18. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins
19. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic
20. Humoral immune response to human papillomavirus infection
21. Seroprevalence of HPV 6 and 16 capsid antibodies in homosexual men
22. Seroprevalence of human papillomavirus type 16 in pregnant women
23. Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts
24. Cervical intraepithelial neoplasia, cervical cancer, and HPV
25. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection
26. Human papillomavirus - The most significant risk determinant of cervical intraepithelial neoplasia
27. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia
28. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
29. Strategies for global control of cervical cancer
30. Genital human papillomavirus infection among male and female sex partners: Prevalence and type-specific concordance
31. Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk women
32. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts
33. Antibody response to a synthetic peptide derived from the human papillomavirus type 6/11 L2 protein in recurrent respiratory papillomatosis: Correlation between Southern blot hybridization, polymerase chain reaction, and serology
34. The natural history of HPV-16 capsid antibodies among a cohort of university women
35. Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes
36. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: Two randomized controlled trials
37. Epidemiology of genital human papillomavirus infection
38. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection
39. HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer rates
40. Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women
41. Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: A nested case control study
42. Natural history of cervicovaginal papillomavirus infection in young women
43. Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia
44. Risk factors for incident and recurrent condylomata acuminata among men. A population-based study